PC_089 Development of a chatbot as a public health strategy to promote health literacy on cervical cancer prevention
B. Belém Luna Sampaio (1), T. Nascimento Moura (2), E. Carla Figueirêdo Vidal (2), H. Maria Furtado Jorge (3), J. Picanço Magalhães (4), A. Fabiane De Andrade Larre (5), A. Reeves De Castro (6), F. Da Mota Almeida Peroni (6), S. Ann Costa Clemens (7), S. De Jesus Silva Bezerra Dos Anjos (7)
(1) Uece, Fortaleza, Brésil, (2) Urca, Crato, Brésil, (3) Ufpi, Teresina, Brésil, (4) Tactium, Fortaleza, Brésil, (5) Instituto Brasileiro De Controle Do Câncer, São Paulo, Brésil, (6) Grupo Mulheres Do Brasil, Fortaleza, Brésil, (7) Johns Hopkins University, Baltimore, États-Unis
PC_066 Test of cure positivity after LLETZ in an era of primary hrHPV screening
Z. Tugcu (1), K. Madani (1), N. Naveendra (1), M. Mcdonald (1), S. Anipindi (1), G. Makosana (1), Y. Gurtovaya (1), S. Chiu (2), D. Marcus (1), H. Staley (1)
(1) Chelsea And Westminster Hospital Nhs Foundation Trust, London, Royaume-Uni, (2) Imperial College London, London, Royaume-Uni
PC_090 Link between Oral lichen planus and rapid cervical HPV infection progression to CIN2+
I. Muryzina, O. Bilodid, V. Lazurenko
Kharkiv National Medical University, Kharkiv, Ukraine
PC_048 State of sustainable practices in France to reduce colposcopy’s environmental impact
M. Schaller, L. Schmutz, C. Brodbeck, C. Gay
Hôpital Nord Franche Comté, Trévenans, France
PC_049 Clinical Utility of an Optoelectronic Imaging Tracing System for Diagnosis of High-Grade Cervical Lesions
Q. Guo, X. Niu, H. Qiu, H. Guo, L. Liu, Z. Liu, L. Han
Department Of Gynecology And Obstetrics, The First Affiliated Hospital Of Zhengzhou University, Zhengzhou, Chine
PC_050 Methylation biomarkers in non-regressive cervical intraepithelial neoplasia grade 2 lesions: an epigenome wide association study
L. Ellis (1), S. Bowden (1), M. Paraskevaidi (1), D. Lyons (2), E. Paraskevaidis (3), B. Moscicki (4), J. Flanagan (1), M. Kyrgiou (1)
(1) Imperial College London, London, Royaume-Uni, (2) Imperial College Healthcare Nhs Trust, London, Royaume-Uni, (3) University Of Ioannina, Ioannina, Grèce, (4) University Of California In Los Angeles, Los Angeles, États-Unis
PC_053 Stratifying risk of premalignant anal lesions among immunocompetent women with genital human papillomavirus virus infection
I. Matas (1), C. Martí (2), A. Cardiel (2), L. Serracanta (2), L. Marimon (2), A. Saco (2), J. Ordi (2), A. Torné (2), M. Del Pino (2)
(1) Hospital Clínic Barcelona – Barcelona (Spain), Barcelona, Espagne, (2) Hospital Clínic Barcelona, Barcelona, Espagne
PC_054 A cross-sectional study on the seroprevalence of 14 HPV neutralizing antibodies among women with current HPV infection who are negative, positive, or at different stages of cervical lesions
T. Li (1), Y. Liu (2), T. Mutailipu (1), M. Li (1), Y. Chang (3), T. Peng (1), Z. Zhang (1), L. Xie (2), W. Chen (1)
(1) National Cancer Center/cancer Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing, Chine, (2) Sinocelltech Ltd., Beijing, Chine, (3) Sichuan Clinical Research Center For Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital Of University Of Electronic Science And Technology Of China, Chengdu, Chine
PC_055 A 13-Year Analysis of HPV-Associated Lower Genital Tract Carcinomas in the Southeastern United States
Y. Ye, P.G. Patel, T. Boitano, S. Shrestha
University Of Alabama At Birmingham, Birmingham, États-Unis
PC_056 Multicentric Disease of the Lower Anogenital Tract: Management and Outcomes
C.S. Salamanca, A.P. Puñal, M.S. Spinosa, S.O.F.I.A. La Valle, L.F. Fleider
Hospital De Clinicas Jose De San Martin, Ciudad De Buenos Aires-Nuñez, Argentine
